FR1624M - Dérivés améliorés de la phénylbutazone. - Google Patents

Dérivés améliorés de la phénylbutazone.

Info

Publication number
FR1624M
FR1624M FR873264A FR873264A FR1624M FR 1624 M FR1624 M FR 1624M FR 873264 A FR873264 A FR 873264A FR 873264 A FR873264 A FR 873264A FR 1624 M FR1624 M FR 1624M
Authority
FR
France
Prior art keywords
phenylbutazone
improved derivatives
derivatives
improved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR873264A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Frederick Co
Original Assignee
Purdue Frederick Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Frederick Co filed Critical Purdue Frederick Co
Priority to FR873264A priority Critical patent/FR1624M/fr
Application granted granted Critical
Publication of FR1624M publication Critical patent/FR1624M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR873264A 1961-09-15 1961-09-15 Dérivés améliorés de la phénylbutazone. Expired FR1624M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR873264A FR1624M (fr) 1961-09-15 1961-09-15 Dérivés améliorés de la phénylbutazone.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR873264A FR1624M (fr) 1961-09-15 1961-09-15 Dérivés améliorés de la phénylbutazone.

Publications (1)

Publication Number Publication Date
FR1624M true FR1624M (fr) 1962-12-26

Family

ID=87699659

Family Applications (1)

Application Number Title Priority Date Filing Date
FR873264A Expired FR1624M (fr) 1961-09-15 1961-09-15 Dérivés améliorés de la phénylbutazone.

Country Status (1)

Country Link
FR (1) FR1624M (fr)

Similar Documents

Publication Publication Date Title
BE622809A (fr) Dérivés de thiaxanthène.
BE614237A (fr) Dérivés de benzimidazols
BE602342A (fr) Dérivés de la Céphalosporine C.
FR1962M (fr) Nouveaux dérivés de la quinoléine.
BE617730A (fr) Dérivés omega-amino-2aryl-3-pyridylalcanamidiques
FR2533M (fr) Nouveaux dérivés de la pipérazine.
FR2075M (fr) Nouveaux dérivés de la 6-méthyl- et de la 1,6-diméthyl-ergoline i.
FR2930M (fr) Dérivés du diméthyldihydroanthracene.
FR1124M (fr) Nouveaux dérivés de 8-benzylxanthines.
FR1769M (fr) Nouveaux dérivés de la pipérazine.
FR2477M (fr) Dérivés aminés des n-cyclopropylbenzylamines.
FR3206M (fr) Dérivés de la 5-méthyl-oxazolidine.
FR1421217A (fr) Nouveaux dérivés pyrimidiniques
FR1397M (fr) Dérivés de benzophénone.
FR1624M (fr) Dérivés améliorés de la phénylbutazone.
FR2446M (fr) Nouveaux dérivés de la pipérazine.
FR1067M (fr) Nouveaux dérivés de la cyclopropyl-5-hydantoine.
FR1622M (fr) Nouveaux dérivés de la phénylbutazone.
FR2255M (fr) Dérivés alpha,alpha-disubstitués de la glutarimide.
FR1086M (fr) Nouveaux dérivés de la n-phénylpipérazine.
FR1939M (fr) Nouveaux dérivés de tétrahydroisoquinoléine.
FR1806M (fr) Nouveaux dérivés de la pipérazine.
BE599879A (fr) Dérivés insaturés de la trihydroxy-acétophénone.
FR1983M (fr) Dérivés du dihydrodibenzocycloheptene.
BE599256R (fr) Dérivés de benzothidiazine